United Health Group Inc. (UNH)$388.47
Research Snapshot
Static fundamentals, valuation context, and investor signals for United Health Group Inc. (UNH).
Valuation
21.4x
EV/FCF, 4.7% FCF yield
Quality
12.0%
ROIC, 3.6% FCF margin
Growth
11.7%
5Y sales (revenue) CAGR
Balance sheet
0.0x
Debt/equity, 0.8x current ratio
Superinvestors
14
Top: Samantha McLemore (4.4%)
Strengths to research
- Revenue compounded at 11.7% over five years.
- Debt/equity looks manageable at 0.0x.
- 14 tracked superinvestors report a position.
- 10 annual periods are available for trend analysis.
Watchouts
- Current ratio is below 1 at 0.8x.
Quality Scorecard
Build-time composite score for UNH.
Peer Comparison
Target stock against 8 market-cap comparable peers.
| UNH Target | United Health Group Inc. | $368.5B | 29.4x | 21.4x | 12.0% | 11.7% | 3.6% | N/A | -1.2x | N/A |
| JNJ | Johnson & Johnson | $372.9B | 21.2x | 20.0x | 21.8% | 2.7% | 20.9% | 67.9% | N/A | N/A |
| ABBV | AbbVie Inc. | $346.8B | 91.4x | 22.8x | 6.9% | 6.0% | 29.1% | N/A | 3.7x | N/A |
| NVO | Novo Nordisk A S | $305.8B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| RHHBY | Roche Holding AG ADR | $265.2B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| RHHVF | Roche Holdings AG DIV RT | $263.8B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| ABT | Abbott Labs | $230.7B | 23.5x | 31.8x | 10.0% | 5.1% | 16.7% | N/A | 0.5x | N/A |
| NVS | Novartis AG | $223.3B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| MRK | Merck & Co. | $208.5B | 16.8x | 15.7x | 34.7% | 9.4% | 19.0% | N/A | N/A | N/A |
Financial Charts
No financial data available for UNH (annual).
14 superinvestors own UNH
Current quarter ownership and quarter-over-quarter share changes.
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Dodge & Cox Dodge & Cox | 9,466,756 | $2.6B | 1.41% | 0.0% |
| Christopher Davis Davis Advisors | 1,247,476 | $338M | 1.55% | 0.0% |
| Mairs & Power Growth Fund Mairs & Power Growth Fund | 741,083 | $201M | 2.05% | 0.0% |
| Ruane Cunniff Sequoia Fund | 728,407 | $197M | 3.27% | 0.0% |
| Samantha McLemore Patient Capital Management | 437,141 | $118M | 4.41% | 0.0% |
| Chase Coleman Tiger Global Management | 350,445 | $95M | 0.42% | 0.0% |
| Yacktman Asset Management Yacktman Asset Management | 168,460 | $46M | 0.61% | 0.0% |
| David Tepper Appaloosa Management | 90,000 | $24M | 0.41% | 0.0% |
| First Eagle Investment Management First Eagle Investment Management | 40,804 | $11M | 0.02% | 0.0% |
| Robert Olstein Olstein Capital Management | 23,000 | $6M | 1.36% | 0.0% |
| Thomas Gayner Markel Group | 18,700 | $5M | 0.04% | 0.0% |
| Hillman Value Fund Hillman Value Fund | 7,405 | $2M | 1.39% | 0.0% |
| Tweedy Browne Co. Tweedy Browne Value Fund | 3,667 | $992,000 | 0.08% | 0.0% |
| Jensen Investment Management Jensen Investment Management | 1,491 | $403,000 | 0.01% | 0.0% |